336 related articles for article (PubMed ID: 26522596)
1. Bioimpedance Assessment of Oral Squamous Cell Carcinoma with Clinicopathological Correlation.
Sarode GS; Sarode SC; Kulkarni M; Karmarkar S; Patll S; Auciustine D
J Contemp Dent Pract; 2015 Sep; 16(9):715-22. PubMed ID: 26522596
[TBL] [Abstract][Full Text] [Related]
2. A preliminary study of the use of bioimpedance in the screening of squamous tongue cancer.
Ching CT; Sun TP; Huang SH; Hsiao CS; Chang CH; Huang SY; Chen YJ; Cheng CS; Shieh HL; Chen CY
Int J Nanomedicine; 2010 Apr; 5():213-20. PubMed ID: 20463937
[TBL] [Abstract][Full Text] [Related]
3. The use of bioimpedance in the detection/screening of tongue cancer.
Sun TP; Ching CT; Cheng CS; Huang SH; Chen YJ; Hsiao CS; Chang CH; Huang SY; Shieh HL; Liu WH; Liu CM; Chen CY
Cancer Epidemiol; 2010 Apr; 34(2):207-11. PubMed ID: 20097150
[TBL] [Abstract][Full Text] [Related]
4. Oral squamous cell carcinoma in the background of oral submucous fibrosis is a distinct clinicopathological entity with better prognosis.
Gadbail AR; Chaudhary M; Gawande M; Hande A; Sarode S; Tekade SA; Korde S; Zade P; Bhowate R; Borle R; Patil S
J Oral Pathol Med; 2017 Jul; 46(6):448-453. PubMed ID: 28129456
[TBL] [Abstract][Full Text] [Related]
5. Serum big endothelin-1 as a biomarker in oral squamous cell carcinoma patients: an analytical study.
Mankapure PK; Barpande SR; Bhavthankar JD; Mandale M
J Appl Oral Sci; 2015 Oct; 23(5):491-6. PubMed ID: 26537720
[TBL] [Abstract][Full Text] [Related]
6. Expression of hepatocyte growth factor and c-met protein is significantly associated with the progression of oral squamous cell carcinoma in Taiwan.
Chen YS; Wang JT; Chang YF; Liu BY; Wang YP; Sun A; Chiang CP
J Oral Pathol Med; 2004 Apr; 33(4):209-17. PubMed ID: 15061708
[TBL] [Abstract][Full Text] [Related]
7. Nuclear fractal dimension in oral squamous cell carcinoma: a novel method for the evaluation of grading, staging, and survival.
Mincione G; Di Nicola M; Di Marcantonio MC; Muraro R; Piattelli A; Rubini C; Penitente E; Piccirilli M; Aprile G; Perrotti V; Artese L
J Oral Pathol Med; 2015 Oct; 44(9):680-4. PubMed ID: 25367085
[TBL] [Abstract][Full Text] [Related]
8. Association of serum and salivary tumor necrosis factor-α with histological grading in oral cancer and its role in differentiating premalignant and malignant oral disease.
Krishnan R; Thayalan DK; Padmanaban R; Ramadas R; Annasamy RK; Anandan N
Asian Pac J Cancer Prev; 2014; 15(17):7141-8. PubMed ID: 25227804
[TBL] [Abstract][Full Text] [Related]
9. Expression of Estrogen Receptors in OSCC in Relation to Histopathological Grade.
Doll C; Arsenic R; Lage H; Jöhrens K; Hartwig S; Nelson K; Raguse JD
Anticancer Res; 2015 Nov; 35(11):5867-72. PubMed ID: 26504009
[TBL] [Abstract][Full Text] [Related]
10. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of glutathione S-transferase pi correlates with poorly differentiated grade in patients with oral squamous cell carcinoma.
Ma HL; Yu C; Liu Y; Tan YR; Qiao JK; Yang X; Wang LZ; Li J; Chen Q; Chen FX; Zhang ZY; Zhong LP
J Oral Pathol Med; 2015 Mar; 44(3):193-200. PubMed ID: 25047743
[TBL] [Abstract][Full Text] [Related]
12. Repression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but not its receptors during oral cancer progression.
Vigneswaran N; Baucum DC; Wu J; Lou Y; Bouquot J; Muller S; Zacharias W
BMC Cancer; 2007 Jun; 7():108. PubMed ID: 17592646
[TBL] [Abstract][Full Text] [Related]
13. The retinoic acid receptor-beta (RAR-beta) mRNA expression in the oral squamous cell carcinoma associated with betel quid use.
Kao SY; Tu HF; Chang KW; Chang CS; Yang CC; Lin SC
J Oral Pathol Med; 2002 Apr; 31(4):220-6. PubMed ID: 12076325
[TBL] [Abstract][Full Text] [Related]
14. Expression of human telomerase reverse transcriptase (hTERT) protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma in Taiwan.
Chen HH; Yu CH; Wang JT; Liu BY; Wang YP; Sun A; Tsai TC; Chiang CP
Oral Oncol; 2007 Feb; 43(2):122-9. PubMed ID: 16798059
[TBL] [Abstract][Full Text] [Related]
15. Monitoring carcinogenesis in a case of oral squamous cell carcinoma using a panel of new metabolic blood biomarkers as liquid biopsies.
Grimm M; Hoefert S; Krimmel M; Biegner T; Feyen O; Teriete P; Reinert S
Oral Maxillofac Surg; 2016 Sep; 20(3):295-302. PubMed ID: 26875085
[TBL] [Abstract][Full Text] [Related]
16. Morphometric computer-assisted image analysis of epithelial cells in different grades of oral squamous cell carcinoma.
Ananjan C; Jyothi M; Laxmidevi BL; Gopinathan PA; Nazir SH; Pradeep L
J Cancer Res Ther; 2018; 14(2):361-367. PubMed ID: 29516920
[TBL] [Abstract][Full Text] [Related]
17. Analysis of tumor marker CA 125 in saliva of normal and oral squamous cell carcinoma patients: a comparative study.
Balan JJ; Rao RS; Premalatha BR; Patil S
J Contemp Dent Pract; 2012 Sep; 13(5):671-5. PubMed ID: 23250173
[TBL] [Abstract][Full Text] [Related]
18. Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.
Jiang T; Xie P; Liu H
J Oral Maxillofac Surg; 2016 Mar; 74(3):650-7. PubMed ID: 26454036
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin expression is an independent factor for poor survival in oral squamous cell carcinoma: a computer-assisted analysis on TMA sections.
Avirović M; Matušan-Ilijaš K; Damante G; Fabrro D; Cerović R; Juretić M; Grahovac B; Jonjić N; Lučin K
J Oral Pathol Med; 2013 Sep; 42(8):620-6. PubMed ID: 23438150
[TBL] [Abstract][Full Text] [Related]
20. Design of a complex bioimpedance spectrometer using DFT and undersampling for neural networks diagnostics.
do Amaral CE; Lopes HS; Arruda LV; Hara MS; Gonçalves AJ; Dias AA
Med Eng Phys; 2011 Apr; 33(3):356-61. PubMed ID: 21146438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
